SCHEMBL7543033

SCHEMBL7543033

O=S(=O)(O)c1c(O)c(S(=O)(=O)O)c2ccccc2c1S(=O)(=O)O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.51
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
DAPK1 P53355 1/20 0.41
PADI4 Q9UM07 1/20 0.39
MPL P40238 3/20 0.38
CYP1A2 P05177 1/20 0.38
CTRB1 P17538 1/20 0.37
POLB P06746 2/20 0.36
LDHA P00338 1/20 0.36
TTR P02766 1/20 0.35
IDO1 P14902 1/20 0.35
LMNA P02545 1/20 0.34
HSP90AA1 P07900 1/20 0.34
KDM4E B2RXH2 1/20 0.34
APEX1 P27695 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
COMT P21964 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL898309 0.89 CYP2D6 (0.46) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
SCHEMBL358739 0.89 CYP2D6 (0.46) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
SCHEMBL9548576 0.89 CYP2D6 (0.50) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
SCHEMBL2524546 0.85 TSHR (0.48) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
SCHEMBL28517657 0.84 CYP2D6 (0.50) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
SCHEMBL8915189 0.84 DAPK1 (0.51) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
Hydrochloric Acid SCHEMBL11755878 0.83 TSHR (0.46) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
SCHEMBL14879315 0.83 TSHR (0.50) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
SCHEMBL8379569 0.79 DAPK1 (0.47) CYP2D6TSHRSMN1; SMN2DAPK1PADI4
SCHEMBL5734148 0.79 DAPK1 (0.51) CYP2D6TSHRSMN1; SMN2DAPK1PADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
US-6313196-B1 FOR INK JET PRINTING; SMUDGE RESISTANCE AGFA-GEVAERT (BE) 2001-11-06 US disclosed
US-6090871-A POLYISOCYANATE HAVING IONIC GROUPS OR POLYETHER GROUPS AND AT LEAST ONE MEMBER SELECTED FROM THE GROUP CONSISTING OF A NATURALLY OCCURRING POLYMER, A POLYSILOXANE GRAFT COPOLYMER, A WATER-DILUTABLE SYNTHETIC POLYMER AND A CATIONIC POLYMER BAYER AKTIENGESELLSCHAFT (DE) 2000-07-18 US disclosed
US-6022449-A HIGHER RETENTION BUT ALSO TO IMPROVED DRY AND WET STRENGTH AND SIZING. BAYER AKTIENGESELLSCHAFT (DE) 2000-02-08 US disclosed
EP-0247457-B1 PROCESS FOR THE PREPARATION OF REAGENT LAYERS CONTAINING HYDROPHOBIC REAGENTS MILES INC. (US) 1993-04-07 EP disclosed
US-5166232-A CELLULOSE/PLASTIC BLENDS, A PROCESS FOR THEIR PRODUCTION AND THEIR USE WOLFF WALSRODE AKTIENGESELLSCHAFT (DE) 1992-11-24 US disclosed
US-5057276-A Dissolving ionomeric polymer and reagent in solvent, adding water, and removing solvent MILES INC. (US) 1991-10-15 US disclosed
EP-0247457-A2 Process for the preparation of reagent layers containing hydrophobic reagents MILES INC. (US) 1987-12-02 EP disclosed
US-4544683-A GYPSUM-POLYURETHANE OR POLYURETHANE-POLYUREA BAYER AKTIENGESELLSCHAFT (DE) 1985-10-01 US disclosed
US-3998804-A PROCESS FOR COUPLING OF WATER-INSOLUBLE 2,4-DISUBSTITUTED PHENOLS WITH DIAZOTIZED O-NITROANILINES CIBA-GEIGY CORPORATION (US) 1976-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 CYP2D6 1331/4885TSHR 4831/4885SMN1; SMN2 2971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.